Results-Older patients represented a small, but increasing, proportion of those investigated. Older patients had more severe symptoms at the time of angiography, were taking more antianginal drugs, and had had their symptoms for longer than younger patients. At angiography more older patients had triple vessel coronary disease, left main stem stenosis, or left ventricular impairment. After angiography similar proportions of older and younger patients underwent coronary artery surgery, with more elderly patients requiring urgent operation; although operative mortality was higher for elderly patients, symptomatic benefit was similar to that in younger patients.
Conclusions-Older patients with angina selected to undergo coronary angiography and subsequent coronary surgery have more severe symptoms and underlying cardiac disease. Earlier referral and investigation might yield a population with lower operative risk. Selection of patients for coronary angiography and coronary artery surgery should be based on the potential for benefit and should avoid "agism."
Introduction
The number of elderly people in the United Kingdom has risen progressively and there has been an associated increase in the prevalence of age related conditions such as angina pectoris. Although cardiology departments have consequently experienced an increase in the number of elderly patients referred for investigation of coronary artery disease, such patients still represent only a small proportion of the total number undergoing coronary angiography. To 
Discussion
In 1990 about 11% of the United Kingdom population was aged over 70 years and 40% was aged 30-70.3 As the prevalence ofangina pectoris in elderly people is approximately 10%,' compared with only 0-6-1-5% in the younger population4 it can be estimated that most people who suffer from angina in the United Kingdom are elderly. Nevertheless, substantially fewer elderly patients with angina undergo investigation by coronary angiography or treatment by coronary artery surgery. In this study patients aged over 70 represented only 5% of all patients having coronary angiography in 1988. Similarly, in the North American coronary artery surgery study only 3% ofpatients undergoing coronary arteriography were aged over 70 years,5 but the current rate of 15-20% for coronary bypass surgery in patients aged over 70 in some American surgical series6 suggests that the angiography rate may also have risen.
Selecting elderly patients for angiography and cardiac surgery is undoubtedly more complex than selecting younger patients. Older patients may be more prepared to reduce their physical activity to live within the limits imposed by their cardiac symptoms, and for some (but not all) the prospect of an improved prognosis is not important. In addition, some elderly patients have other medical problems which may compromise their capacity to survive or to recover from major surgery.
In our study, over an 11 year period those elderly patients who were selected for angiography differed substantially from younger patients. Elderly patients had more severe angina, were more likely to be hospitalised with unstable angina, were taking more antianginal drugs, and had been treated medically for a longer period; this suggests that quite different referral and selection policies for coronary angiography were applied to older and younger patients with angina, although we cannot at present determine whether this Initial andfinal allocations to treatment for older andyounger patients after coronary angiography imiography = 9 ---o--l*died '7 I occurred at the level of patient, general practitioner, general physician, or cardiologist. At angiography elderly patients had more severe and extensive coronary disease and had developed greater myocardial impairment, and as these factors, the severity of symptoms, and the need for urgent surgery have all been identified as predictors of surgical mortality6 these patients have an intrinsically higher operative risk, even before the effect of age is considered. We believe, therefore, that earlier referral and investigation of elderly patients who may be candidates for cardiac surgery-at a stage when their symptoms are limiting but not yet unstable-would yield a group for whom surgery could provide important symptomatic benefit, but at lower risk.
The implementation of such a policy would, in the context of our changing demography, place increased stress on already seriously overextended cardiac diagnostic facilities and staffing.7 Additionally, the provision of cardiac surgery within the NHS has tended to be restricted, and most cardiac surgery units have long waiting lists, often extending to over a year for nonurgent cases. In such circumstances of limited resources there is a danger that the medical needs of elderly patients may be looked on less favourably than those of younger patients, a prejudice termed agism.8 Although this method of discriminating between patients competing for a finite resource may be convenient, it is rarely rational, and we are not aware of any public consensus regarding prejudicial selection on the grounds of age as a means of distributing treatment within the NHS. If finite resources require some patients to receive less than optimal treatment then this should be enacted by excluding those with less potential for benefit. Setting-Trials had been conducted in hospital clinics (6), industry (3), mental hospitals or institutions (3), and in general populations (4).
Patients-Trials had been conducted in high risk subjects (5), in unselected healthy subjects (6), or for secondary prevention in patients with coronary heart disease (5). Women were included in only four trials.
Interventions-Diets equivalent to the step 1 diet were employed in eight trials, with individual intervention by dietitians (3) or occupational physicians (2) or with population advice (3). Intensive diets which were more rigorous than the step 2 diet were employed in eight trials.
Main outcome measures-Net change in serum total cholesterol concentration in subjects receiving treatment with diet compared with values in control subjects after six months to 10 years.
Results-In five trials with the step 1 diet as individual intervention the net reduction in serum cholesterol concentration ranged from 0% to 4*0% over six months to six years. In trials with population education reductions in cholesterol concentrations were 0-6-2-0% over five to 10 years. When population and individual dietary advice were combined changes in cholesterol concentration ranged from a fall of 2-1% to a rise of 1-0% over four to 10 years. Diets more intensive than the step 2 diet reduced serum cholesterol concentration by 13% over five years in selected high risk men in the population; by 6-5-15*1% over two to five years in hospital outpatients; and by 12-8-15-5% over one to four and a halfyears in patients in institutions.
Conclusions-The response to a step 1 diet is too small to have any value in the clinical management of adults with serum cholesterol concentrations above 6-5 mmol/l. Current guidelines recommend screening of serum cholesterol concentration in healthy subjects, foliowed by treatment with a step 1 diet. The guidelines should be reviewed to provide a more realistic estimate of the effect of a step 1 diet and of the likely need for lipid lowering drugs.
Introduction
Every 1% reduction in serum cholesterol concentration reduces the risk of coronary events by about 1-2%.' Guidelines for managing patients with high cholesterol concentrations concur that diet is of prime importance in management,2-7 and advocate as initial treatment the step 1,6 or general lipid lowering diet (box).8 If this proves insufficient the more intensive step 2 diet is advised (box).6 These recommendations are based on epidemiological considerations9 and short term experiments.'0 Estimates of cholesterol reduction by the step 1 diet range from 10% to 25%,68 but there are suggestions that it may be insufficiently effective. "I'3 In Britain about 40% of adults have serum cholesterol concentrations in the moderate to high risk category and are therefore considered to need clinical care,'4'16 and a standing medical advisory committee has emphasised that cost effective management BMJ VOLUME 303
